TrialThe journal of headache and pain2024

Double-blind, randomized, placebo-controlled study to evaluate erenumab-specific central effects: an fMRI study.

Hauke Basedau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.